Cas9 was initially discovered as part of the CRISPR system, which bacteria use to defend against invading viruses and plasmids. The system works by capturing snippets of DNA from invaders and incorporating them into the bacterial genome as “spacers” between the CRISPR sequences. When the bacterium encounters the same invader again, it transcribes these spacers into RNA, which guides the Cas9 protein to the matching DNA sequence in the invader. Cas9 then cleaves the DNA, neutralizing the threat .
The Cas9 protein operates by unwinding the target DNA and checking for a sequence complementary to the guide RNA (gRNA). If a match is found, Cas9 induces a double-strand break in the DNA. This mechanism is highly specific due to the RNA-DNA complementarity, making Cas9 a powerful tool for precise genome editing .
The ability of Cas9 to induce site-specific double-strand breaks has been harnessed for various applications in genetic engineering. By designing specific gRNAs, scientists can target almost any gene in a genome, allowing for gene knockout, insertion, or correction. This has profound implications for research, medicine, and biotechnology .
Recombinant Cas9 refers to the Cas9 protein that has been produced through recombinant DNA technology. This involves inserting the Cas9 gene into an expression system, such as Escherichia coli, to produce large quantities of the protein. Recombinant Cas9 is essential for laboratory applications, where it is used in conjunction with synthetic gRNAs to edit genes in various organisms .
Research on Cas9 has led to the development of various Cas9 variants to overcome limitations and enhance its functionality. For example, Cas9 nickase (Cas9n) induces single-strand breaks instead of double-strand breaks, reducing off-target effects. Other variants have been engineered to recognize different PAM (Protospacer Adjacent Motif) sequences, broadening the range of targetable DNA sequences .